Controlled retrospective study of the effects of eyedrops containing phenylephrine hydrochloride and scopolamine hydrobromide on mean arterial blood pressure in anesthetized dogs

Manuel Martin-FloresDepartment of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853.

Search for other papers by Manuel Martin-Flores in
Current site
Google Scholar
PubMed
Close
 MV
,
Tara M. Mercure-McKenzieDepartment of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853.

Search for other papers by Tara M. Mercure-McKenzie in
Current site
Google Scholar
PubMed
Close
 LVT
,
Luis CampoyDepartment of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853.

Search for other papers by Luis Campoy in
Current site
Google Scholar
PubMed
Close
 LV
,
Hollis N. ErbDepartment of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853.

Search for other papers by Hollis N. Erb in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
John W. LuddersDepartment of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853.

Search for other papers by John W. Ludders in
Current site
Google Scholar
PubMed
Close
 DVM
, and
Robin D. GleedDepartment of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853.

Search for other papers by Robin D. Gleed in
Current site
Google Scholar
PubMed
Close
 BVSc, MA
View More View Less

Abstract

Objective—To determine whether dogs that received eyedrops containing phenylephrine and scopolamine would have a higher mean arterial blood pressure (MAP) when anesthetized than would dogs that did not receive the eyedrops.

Animals—37 nondiabetic and 29 diabetic dogs anesthetized for phacoemulsification and 15 nondiabetic dogs anesthetized for corneal ulcer repair (control dogs).

Procedures—Medical records were reviewed to identify study dogs. Dogs undergoing phacoemulsification received 2 types of eyedrops (10% phenylephrine hydrochloride and 0.3% scopolamine hydrobromide) 4 times during a 2-hour period prior to the procedure. Control dogs did not receive these eyedrops. Heart rate and MAP were measured before surgery in all dogs 10 and 5 minutes before, at the time of (t0), and 5 (t5) and 10 (t10) minutes after atracurium administration.

Results—MAP was greater in the 2 groups that received the eyedrops than in the control group at t0 and t5; at t10, it was greater only for the nondiabetic dogs that received eyedrops. Nine nondiabetic dogs and 1 diabetic dog anesthetized for phacoemulsification had at least 1 MAP value > 131 mm Hg; 73% of MAP values > 131 mm Hg were detected within 10 minutes after atracurium administration. At no time did a control dog have an MAP value > 131 mm Hg.

Conclusions and Clinical Relevance—Anesthetized dogs pretreated with eyedrops containing phenylephrine and scopolamine had higher MAP values than dogs that did not receive the eyedrops, suggesting the drops caused hypertension. Atracurium may interact with the eyedrops and contribute to the hypertension.

Abstract

Objective—To determine whether dogs that received eyedrops containing phenylephrine and scopolamine would have a higher mean arterial blood pressure (MAP) when anesthetized than would dogs that did not receive the eyedrops.

Animals—37 nondiabetic and 29 diabetic dogs anesthetized for phacoemulsification and 15 nondiabetic dogs anesthetized for corneal ulcer repair (control dogs).

Procedures—Medical records were reviewed to identify study dogs. Dogs undergoing phacoemulsification received 2 types of eyedrops (10% phenylephrine hydrochloride and 0.3% scopolamine hydrobromide) 4 times during a 2-hour period prior to the procedure. Control dogs did not receive these eyedrops. Heart rate and MAP were measured before surgery in all dogs 10 and 5 minutes before, at the time of (t0), and 5 (t5) and 10 (t10) minutes after atracurium administration.

Results—MAP was greater in the 2 groups that received the eyedrops than in the control group at t0 and t5; at t10, it was greater only for the nondiabetic dogs that received eyedrops. Nine nondiabetic dogs and 1 diabetic dog anesthetized for phacoemulsification had at least 1 MAP value > 131 mm Hg; 73% of MAP values > 131 mm Hg were detected within 10 minutes after atracurium administration. At no time did a control dog have an MAP value > 131 mm Hg.

Conclusions and Clinical Relevance—Anesthetized dogs pretreated with eyedrops containing phenylephrine and scopolamine had higher MAP values than dogs that did not receive the eyedrops, suggesting the drops caused hypertension. Atracurium may interact with the eyedrops and contribute to the hypertension.

Contributor Notes

Address correspondence to Dr. Martin-Flores (mm459@cornell.edu).
  • 1

    McMurphy RM, Stoll MR & McCubrey R. Accuracy of an oscillometric blood pressure monitor during phenylephrine-induced hypertension in dogs. Am J Vet Res 2006; 67:15411545.

    • Search Google Scholar
    • Export Citation
  • 2

    Herring I P, Jacobson JD, Pickett J P. Cardiovascular effects of topical ophthalmic 10% phenylephrine in dogs. Vet Ophthalmol 2004; 7:4146.

    • Search Google Scholar
    • Export Citation
  • 3

    Kantelip J P, Alatienne M, Gueorguiev G, et al. Chronotropic and dromotropic effects of atropine and hyoscine methobromide in unanaesthetized dogs. Br J Anaesth 1985; 57:214219.

    • Search Google Scholar
    • Export Citation
  • 4

    Vinik AI, Maser RE, Mitchell BD, et al. Diabetic autonomic neuropathy. Diabetes Care 2003; 26:15531579.

  • 5

    Kenefick S, Parker N, Slater L, et al. Evidence of cardiac autonomic neuropathy in dogs with diabetes mellitus. Vet Rec 2007; 161:8388.

  • 6

    Brown S, Atkins C, Bagley R, et al. Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats. J Vet Intern Med 2007; 21:542558.

    • Search Google Scholar
    • Export Citation
  • 7

    Basta SJ, Ali HH, Savarese JJ, et al. Clinical pharmacology of atracurium besylate (BW 33A): a new non-depolarizing muscle relaxant. Anesth Analg 1982; 61:723729.

    • Search Google Scholar
    • Export Citation
  • 8

    Siler JN, Mager JG Jr, Wyche MQ Jr. Atracurium: hypotension, tachycardia and bronchospasm. Anesthesiology 1985; 62:645646.

  • 9

    Sawyer DC, Guikema AH, Siegel EM. Evaluation of a new oscillometric blood pressure monitor in isoflurane-anesthetized dogs. Vet Anaesth Analg 2004; 31:2739.

    • Search Google Scholar
    • Export Citation
  • 10

    Pascoe PJ, Ilkiw JE, Stiles J, et al. Arterial hypertension associated with topical ocular use of phenylephrine in dogs. J Am Vet Med Assoc 1994; 205:15621564.

    • Search Google Scholar
    • Export Citation
  • 11

    Meyer RE. Anesthesia of pediatric small animal patients. In: Recent advances in veterinary anesthesia and analgesia: companion animals. Available at: www.ivis.org/advances/Anesthesia_Gleed/meyer2/chapter.asp?LA=1. Accessed Oct 5, 2009.

    • Search Google Scholar
    • Export Citation
  • 12

    Hackett GH, Jantzen J P & Earnshaw G. Cardiovascular effects of vecuronium, atracurium, pancuronium, metocurine and RGH-4201 in dogs. Acta Anaesthesiol Scand 1989; 33:298303.

    • Search Google Scholar
    • Export Citation
  • 13

    Amaranath L, Zanettin GG, Bravo EL, et al. Atracurium and pheochromocytoma: a report of three cases. Anesth Analg 1988; 67:11271130.

  • 14

    Sides CA. Hypertension during anesthesia with monoamine oxidase inhibitors. Anaesthesia 1987; 42:633635.

Advertisement